Subjects: DOR, QUALIDADE DE VIDA, ESPASTICIDADE MUSCULAR, ACIDENTE VASCULAR CEREBRAL
ABNT
KHAN, Patricia et al. The effectiveness of botulinum toxin type A (BoNT-A) treatment in brazilian patients with chronic post-stroke spasticity: results from the observational, multicenter, prospective BCause study. Toxins, v. 12, n. 12, 2020Tradução . . Disponível em: https://doi.org/10.3390/toxins12120770. Acesso em: 04 nov. 2024.APA
Khan, P., Riberto, M., Frances, J. A., Chueire, R., Amorim, A. C. F. G., Xerez, D., et al. (2020). The effectiveness of botulinum toxin type A (BoNT-A) treatment in brazilian patients with chronic post-stroke spasticity: results from the observational, multicenter, prospective BCause study. Toxins, 12( 12). doi:10.3390/toxins12120770NLM
Khan P, Riberto M, Frances JA, Chueire R, Amorim ACFG, Xerez D, Chung TM, Mercuri LHC, Longo AL, Lianza S, Maisonobe P, Ruiz-Schutz VC. The effectiveness of botulinum toxin type A (BoNT-A) treatment in brazilian patients with chronic post-stroke spasticity: results from the observational, multicenter, prospective BCause study [Internet]. Toxins. 2020 ; 12( 12):[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/toxins12120770Vancouver
Khan P, Riberto M, Frances JA, Chueire R, Amorim ACFG, Xerez D, Chung TM, Mercuri LHC, Longo AL, Lianza S, Maisonobe P, Ruiz-Schutz VC. The effectiveness of botulinum toxin type A (BoNT-A) treatment in brazilian patients with chronic post-stroke spasticity: results from the observational, multicenter, prospective BCause study [Internet]. Toxins. 2020 ; 12( 12):[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/toxins12120770